Literature DB >> 24880818

Membranous nephropathy associated with angiomatoid fibrous histiocytoma in a pediatric patient.

Mira A Kohorst1, Cheryl L Tran, Andrew L Folpe, Sanjeev Sethi, Carola A S Arndt.   

Abstract

BACKGROUND: Though membranous nephropathy is a much more common cause of nephrotic syndrome in the adult population, it accounts for only a small fraction of cases in pediatrics. CASE-DIAGNOSIS/TREATMENT: We report a case of a 16-year-old boy with nephrotic syndrome due to membranous nephropathy in the setting of a rare tumor, angiomatoid fibrous histiocytoma. This patient's nephrotic-range proteinuria completely resolved following resection of this tumor. Angiomatoid fibrous histiocytoma, while known to cause other paraneoplastic syndromes such as anemia, has never been reported to cause membranous nephropathy.
CONCLUSIONS: This case highlights a novel and treatable secondary cause of membranous nephropathy. Because secondary causes are more common in children than in adults, a high index of suspicion for other underlying pathology including malignancy should be considered. It also suggests that urinalysis may be a helpful screening tool in cases of angiomatoid fibrous histiocytoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880818     DOI: 10.1007/s00467-014-2852-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Membranous nephropathy and orbital malignant tumor.

Authors:  F Tourneur; R Bouvier; J Langue; M H Saïd; C Bergeron; M Hermier; P Cochat
Journal:  Pediatr Nephrol       Date:  2000-01       Impact factor: 3.714

2.  Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.

Authors:  C Lefaucheur; B Stengel; D Nochy; P Martel; G S Hill; C Jacquot; J Rossert
Journal:  Kidney Int       Date:  2006-08-30       Impact factor: 10.612

Review 3.  Paraneoplastic glomerular diseases and malignancies.

Authors:  Justine Bacchetta; Laurent Juillard; Pierre Cochat; Jean-Pierre Droz
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-14       Impact factor: 6.312

4.  Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases.

Authors:  G Pettinato; J C Manivel; G De Rosa; G Petrella; W Jaszcz
Journal:  Mod Pathol       Date:  1990-07       Impact factor: 7.842

5.  An unusual case of membranous nephropathy associated with an ovarian tumor.

Authors:  Ashton Chen; Mark Vander Lugt; Linda M McAllister-Lucas; Paul D Killen; Neal B Blatt
Journal:  Pediatr Nephrol       Date:  2011-09-04       Impact factor: 3.714

Review 6.  The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review.

Authors:  Cyril Fisher
Journal:  Histopathology       Date:  2013-11-06       Impact factor: 5.087

Review 7.  Membranous nephropathy associated with ovarian tumour in a young girl: recovery after removal.

Authors:  P Beauvais; G Vaudour; L Boccon Gibod; M Levy
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

8.  Neuroblastoma presenting with the nephrotic syndrome.

Authors:  H L Zheng; T Maruyama; S Matsuda; K Satomura
Journal:  J Pediatr Surg       Date:  1979-08       Impact factor: 2.545

9.  Membranous glomerulonephritis: treatment response and outcome in children.

Authors:  Rudolph P Valentini; Tej K Mattoo; Gaurav Kapur; Abubakr Imam
Journal:  Pediatr Nephrol       Date:  2008-10-10       Impact factor: 3.714

Review 10.  Membranous nephropathy in children: clinical presentation and therapeutic approach.

Authors:  Shina Menon; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2009-11-12       Impact factor: 3.714

View more
  1 in total

1.  Atypical thymic carcinoid manifesting with nephrotic-range proteinuria in a 7-year-old boy.

Authors:  Jolanta Soltysiak; Danuta Ostalska-Nowicka; Katarzyna Zaorska; Karolina Sterzyńska; Katarzyna Derwich; Jacek Zachwieja
Journal:  Pediatr Nephrol       Date:  2017-05-05       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.